The capital expenditure plan at POSCO PKX POSCO Posts Deep Loss 1717 Negative EPS Miss NKTR Nektar Therapeutics posts narrower Q4 2025 loss than estimates shares gain 167 percent in todays session EHTH eHealth shares rally almost 10 percent after Q4 2025 EPS narrowly misses consensus analyst forecasts iShares MSCI China ETF MCHI Positioned to Benefit From End of Chinas 3Year Factory Deflation Cycle Biogen Inc BIIB Valuation Assessment Following a 515 12Month Share Price Rally Johnson Johnson JNJ Gains From CoPartnered HIV Portfolio Performance In GSKs Strong Q1 2026 Earnings Beat Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Worksport WKSP Stock Technical Chart Overview Q4 2025 Profit Disappoints NAMS NewAmsterdam misses Q4 2025 EPS estimates by wide margin shares dip 101 percent today OXSQH Oxford releases quarterly earnings report with key performance metrics still unavailable to public investors